MicroRNAs in cardiovascular ageing

Journal of Physiology

Volumn 594, Issue 8, 2016, Pages 2085-2094

  Seeger, Timon ^a,b   Boon, Reinier A ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GOETHE UNIVERSITY   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 144; MICRORNA 15; MICRORNA 18; MICRORNA 181; MICRORNA 19; MICRORNA 199; MICRORNA 208; MICRORNA 21; MICRORNA 214; MICRORNA 217; MICRORNA 22; MICRORNA 25; MICRORNA 26; MICRORNA 29; MICRORNA 30; MICRORNA 328; MICRORNA 34; MICRORNA 378; MICRORNA 451; MICRORNA 499; MICRORNA 92; MIRAVIRSEN; UNCLASSIFIED DRUG;

AGING; AORTA ANEURYSM; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; CARDIOVASCULAR AGING; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEPATITIS C; HUMAN; HYPERTENSION; IMMUNOSENESCENCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; CAENORHABDITIS ELEGANS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DISEASE MODEL; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM;

ANIMALS; CAENORHABDITIS ELEGANS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DISEASE MODELS, ANIMAL; HUMANS; MICRORNAS;

EID: 84934783609     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP270557     Document Type: Review

References (106)

1. Abonnenc M, Nabeebaccus AA, Mayr U, Barallobre-Barreiro J, Dong X, Cuello F, Sur S, Drozdov I, Langley SR, Lu R, Stathopoulou K, Didangelos A, Yin X, Zimmermann W-H, Shah AM, Zampetaki A & Mayr M (2013). Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. Circ Res 113, 1138-1147.
2. 6-methyladenosine marks primary microRNAs for processing. Nature 519, 482-485.
3. Badi I, Burba I, Ruggeri C, Zeni F, Bertolotti M, Scopece A, Pompilio G & Raucci A (2014). MicroRNA-34a induces vascular smooth muscle cells senescence by SIRT1 downregulation and promotes the expression of age-associated pro-inflammatory secretory factors. J Gerontol A Biol Sci Med Sci 70, 1304-1311.
4. Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, Holzmann A, Just A, Remke J, Zimmer K, Zeug A, Ponimaskin E, Schmiedl A, Yin X, Mayr M, Halder R, Fischer A, Engelhardt S, Wei Y, Schober A, Fiedler J & Thum T (2014). Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 124, 2136-2146.
5. Bartel DP (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
6. Bátkai S & Thum T (2012). MicroRNAs in hypertension: mechanisms and therapeutic targets. Curr Hypertens Rep 14, 79-87.
7. Beltrami C, Angelini TG & Emanueli C (2014). Noncoding RNAs in diabetes vascular complications. J Mol Cell Cardiol 89, 42-50.
8. Bernardo BC, Gao X-M, Winbanks CE, Boey EJH, Tham YK, Kiriazis H, Gregorevic P, Obad S, Kauppinen S, Du X-J, Lin RCY & McMullen JR (2012). Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci U S A 109, 17615-17620.
9. Bernstein E, Caudy AA, Hammond SM & Hannon GJ (2001). Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363-366.
10. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, Mills AA, Elledge SJ, Anderson KV & Hannon GJ (2003). Dicer is essential for mouse development. Nat Genet 35, 215-217.
11. Bohnsack MT, Czaplinski K & Gorlich D (2004). Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 10, 185-191.
12. Boon RA & Dimmeler S (2014). MicroRNAs in myocardial infarction. Nat Rev Cardiol 12, 135-142.
13. Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, Heydt S, Kaluza D, Tréguer K, Carmona G, Bonauer A, Horrevoets AJ, Didier N, Girmatsion Z, Biliczki P, Ehrlich JR, Katus HA, Müller OJ, Potente M, Zeiher AM, Hermeking H & Dimmeler S (2013). MicroRNA-34a regulates cardiac ageing and function. Nature 495, 107-110.
14. Boon RA, Seeger T, Heydt S, Fischer A, Hergenreider E, Horrevoets AJ, Vinciguerra M, Rosenthal N, Sciacca S, Pilato M, vanHeijningen P, Essers J, Brandes RP, Zeiher AM & Dimmeler S (2011). MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res 109, 1115-1119.
15. Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Høydal M, Autore C, Russo MA, Dorn GW 2nd, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C & Condorelli G (2007). MicroRNA-133 controls cardiac hypertrophy. Nat Med 13, 613-618.
16. Chen J-F, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z, Rojas M, Hammond SM, Schneider MD, Selzman CH, Meissner G, Patterson C, Hannon GJ & Wang D-Z (2008). Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci U S A 105, 2111-2116.
17. Chen Z, Wen L, Martin M, Hsu C-Y, Fang L, Lin F-M, Lin T-Y, Geary MJ, Geary GG, Zhao Y, Johnson DA, Chen J-W, Lin S-J, Chien S, Huang H-D, Miller YI, Huang P-H & Shyy JY-J (2015). Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a. Circulation 131, 805-814.
18. Chong MMW, Zhang G, Cheloufi S, Neubert TA, Hannon GJ & Littman DR (2010). Canonical and alternate functions of the microRNA biogenesis machinery. Genes Dev 24, 1951-1960.
19. Csiszar A, Gautam T, Sosnowska D, Tarantini S, Banki E, Tucsek Z, Toth P, Losonczy G, Koller A, Reglodi D, Giles CB, Wren JD, Sonntag WE & Ungvari Z (2014). Caloric restriction confers persistent anti-oxidative, pro-angiogenic, and anti-inflammatory effects and promotes anti-aging miRNA expression profile in cerebromicrovascular endothelial cells of aged rats. Am J Physiol Heart Circ Physiol 307, H292-H306.
20. Da Costa Martins PA, Salic K, Gladka MM, Armand A-S, Leptidis S, el Azzouzi H, Hansen A, Coenen-de Roo CJ, Bierhuizen MF, van der Nagel R, van Kuik J, de Weger R, deBruin A, Condorelli G, Arbones ML, Eschenhagen T & DeWindt LJ (2010). MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 12, 1220-1227.
21. Das S, Ferlito M, Kent OA, Fox-Talbot K, Wang R, Liu D, Raghavachari N, Yang Y, Wheelan SJ, Murphy E & Steenbergen C (2012). Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res 110, 1596-1603.
22. Dawson K, Wakili R, Ordög B, Clauss S, Chen Y, Iwasaki Y, Voigt N, Qi XY, Sinner MF, Dobrev D, Kääb S & Nattel S (2013). MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation 127, 1466-1475, 1475e1-e28.
23. Denli AM, Tops BBJ, Plasterk RHA, Ketting RF & Hannon GJ (2004). Processing of primary microRNAs by the Microprocessor complex. Nature 432, 231-235.
24. Dimitrakopoulou K, Vrahatis AG & Bezerianos A (2015). Integromics network meta-analysis on cardiac aging offers robust multi-layer modular signatures and reveals micronome synergism. BMC Genomics 16, 147.
25. Dirkx E, Gladka MM, Philippen LE, Armand AS, Kinet V, Leptidis S, El Azzouzi H, Salic K, Bourajjaj M, da Silva GJ, Olieslagers S, van der Nagel R, deWeger R, Bitsch N, Kisters N, Seyen S, Morikawa Y, Chanoine C, Heymans S, Volders PG, Thum T, Dimmeler S, Cserjesi P, Eschenhagen T, da Costa Martins PA & DeWindt LJ (2013). Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure. Nat Cell Biol 15, 1282-1293.
26. el Azzouzi H, Leptidis S, Dirkx E, Hoeks J, van Bree B, Brand K, McClellan EA, Poels E, Sluimer JC, van den Hoogenhof MM, Armand AS, Yin X, Langley S, Bourajjaj M, Olieslagers S, Krishnan J, Vooijs M, Kurihara H, Stubbs A, Pinto YM, Krek W, Mayr M, da Costa Martins PA, Schrauwen P & DeWindt LJ (2013). The hypoxia-inducible microRNA cluster miR-199a∼214 targets myocardial PPARδ and impairs mitochondrial fatty acid oxidation. Cell Metab 18, 341-354.
27. Fernández-Hernando C, Ramírez CM, Goedeke L & Suárez Y (2013). MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol 33, 178-185.
28. Fichtlscherer S, Zeiher AM & Dimmeler S (2011). Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 31, 2383-2390.
29. Flierl U, Nero TL, Lim B, Arthur JF, Yao Y, Jung SM, Gitz E, Pollitt AY, Zaldivia MTK, Jandrot-Perrus M, Schäfer A, Nieswandt B, Andrews RK, Parker MW, Gardiner EE & Peter K (2015). Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators. J Exp Med 212, 129-137.
30. Gagnon KT, Li L, Chu Y, Janowski BA & Corey DR (2014). RNAi factors are present and active in human cell nuclei. Cell Rep 6, 211-221.
31. Ganesan J, Ramanujam D, Sassi Y, Ahles A, Jentzsch C, Werfel S, Leierseder S, Loyer X, Giacca M, Zentilin L, Thum T, Laggerbauer B & Engelhardt S (2013). MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors. Circulation 127, 2097-2106.
32. K1 up-regulation in human atrial fibrillation. Heart Rhythm 6, 1802-1809.
33. Gombar S, Jung HJ, Dong F, Calder B, Atzmon G, Barzilai N, Tian X-L, Pothof J, Hoeijmakers JHJ, Campisi J, Vijg J & Suh Y (2012). Comprehensive microRNA profiling in B-cells of human centenarians by massively parallel sequencing. BMC Genomics 13, 353.
34. Greco S, Gorospe M & Martelli F (2015). Noncoding RNA in age-related cardiovascular diseases. J Mol Cell Cardiol 83, 142-155.
35. Gregory RI, Yan K-P, Amuthan G, Chendrimada T, Doratotaj B, Cooch N & Shiekhattar R (2004). The Microprocessor complex mediates the genesis of microRNAs. Nature 432, 235-240.
36. Guay C & Regazzi R (2013). Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol 9, 513-521.
37. Ha M & Kim VN (2014). Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15, 509-524.
38. Haigis MC & Guarente LP (2006). Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev 20, 2913-2921.
39. He L, He X, Lim LP, deStanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA & Hannon GJ (2007). A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134.
40. Hermeking H (2010). The miR-34 family in cancer and apoptosis. Cell Death Differ 17, 193-199.
41. Hermeking H (2012). MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 12, 613-626.
42. Hinkel R, Penzkofer D, Zühlke S, Fischer A, Husada W, Xu Q-F, Baloch E, van Rooij E, Zeiher AM, Kupatt C & Dimmeler S (2013). Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model. Circulation 128, 1066-1075.
43. Huang Z-P, Chen J, Seok HY, Zhang Z, Kataoka M, Hu X & Wang D-Z (2013). MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ Res 112, 1234-1243.
44. Huntzinger E & Izaurralde E (2011). Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12, 99-110.
45. Hutvágner G, McLachlan J, Pasquinelli AE, Bálint E, Tuschl T & Zamore PD (2001). A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834-838.
46. Ito T, Yagi S & Yamakuchi M (2010). MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun 398, 735-740.
47. Janssen HLA, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, vander Meer AJ, Patick AK, Chen A, Zhou Y, Persson R, King BD, Kauppinen S, Levin AA & Hodges MR (2013). Treatment of HCV infection by targeting microRNA. N Engl J Med 368, 1685-1694.
48. Jazbutyte V, Fiedler J, Kneitz S, Galuppo P, Just A, Holzmann A, Bauersachs J & Thum T (2013). MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart. Age (Dordr) 35, 747-762.
49. Kozomara A & Griffiths-Jones S (2014). miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42, D68-D73.
50. Kumar S, Kim CW, Simmons RD & Jo H (2014). Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs. Arterioscler Thromb Vasc Biol 34, 2206-2216.
51. Kuwabara Y, Horie T, Baba O, Watanabe S, Nishiga M, Usami S, Izuhara M, Nakao T, Nishino T, Otsu K, Kita T, Kimura T & Ono K (2015). MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway. Circ Res 116, 279-288.
52. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S & Orum H (2010). Therapeutic silencing of MicroRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198-201.
53. Lee RC & Ambros V (2001). An extensive class of small RNAs in Caenorhabditis elegans. Science 294, 862-864.
54. Lee RC, Feinbaum RL & Ambros V (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854.
55. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Rådmark O, Kim S & Kim VN (2003). The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415-419.
56. Lee Y, Kim M, Han J, Yeom K-H, Lee S, Baek SH & Kim VN (2004). MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23, 4051-4060.
57. Li X, Khanna A, Li N & Wang E (2011). Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging. Aging (Albany NY) 3, 985-1002.
58. Lin S-L, Miller JD & Ying S-Y (2006). Intronic microRNA (miRNA). J Biomed Biotechnol 2006, 26818.
59. Ling S, Nanhwan M, Qian J, Kodakandla M, Castillo AC, Thomas B, Liu H & Ye Y (2013a). Modulation of microRNAs in hypertension-induced arterial remodeling through the β1 and β3-adrenoreceptor pathways. J Mol Cell Cardiol 65, 127-136.
60. Ling T-Y, Wang X-L, Chai Q, Lau T-W, Koestler CM, Park SJ, Daly RC, Greason KL, Jen J, Wu L-Q, Shen W-F, Shen W-K, Cha Y-M & Lee H-C (2013b). Regulation of the SK3 channel by microRNA-499 - potential role in atrial fibrillation. Heart Rhythm 10, 1001-1009.
61. Liu J, Carmell MA, Rivas F V, Marsden CG, Thomson JM, Song J-J, Hammond SM, Joshua-Tor L & Hannon GJ (2004). Argonaute2 is the catalytic engine of mammalian RNAi. Science 305, 1437-1441.
62. Loffredo FS, Nikolova AP, Pancoast JR & Lee RT (2014). Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium. Circ Res 115, 97-107.
63. Lu Y, Zhang Y, Wang N, Pan Z, Gao X, Zhang F, Zhang Y, Shan H, Luo X, Bai Y, Sun L, Song W, Xu C, Wang Z & Yang B (2010). MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 122, 2378-2387.
64. Lund E, Güttinger S, Calado A, Dahlberg JE & Kutay U (2004). Nuclear export of microRNA precursors. Science 303, 95-98.
65. Luo X, Pan Z, Shan H, Xiao J, Sun X, Wang N, Lin H, Xiao L, Maguy A, Qi XY, Li Y, Gao X, Dong D, Zhang Y, Bai Y, Ai J, Sun L, Lu H, Luo XY, Wang Z, Lu Y, Yang B & Nattel S (2013). MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J Clin Invest 123, 1939-1951.
66. Maegdefessel L, Azuma J, Toh R, Merk DR, Deng A, Chin JT, Raaz U, Schoelmerich AM, Raiesdana A, Leeper NJ, McConnell MV, Dalman RL, Spin JM & Tsao PS (2012). Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest 122, 497-506.
67. Magenta A, Greco S, Gaetano C & Martelli F (2013). Oxidative stress and microRNAs in vascular diseases. Int J Mol Sci 14, 17319-17346.
68. Meder B, Backes C, Haas J, Leidinger P, Stähler C, Großmann T, Vogel B, Frese K, Giannitsis E, Katus HA, Meese E & Keller A (2014). Influence of the confounding factors age and sex on microRNA profiles from peripheral blood. Clin Chem 60, 1200-1208.
69. Menghini R, Casagrande V, Cardellini M, Martelli E, Terrinoni A, Amati F, Vasa-Nicotera M, Ippoliti A, Novelli G, Melino G, Lauro R & Federici M (2009). MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120, 1524-1532.
70. Menghini R, Stöhr R & Federici M (2014). MicroRNAs in vascular aging and atherosclerosis. Ageing Res Rev 17, 68-78.
71. Nishi H, Ono K, Iwanaga Y, Horie T, Nagao K, Takemura G, Kinoshita M, Kuwabara Y, Mori RT, Hasegawa K, Kita T & Kimura T (2010). MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. J Biol Chem 285, 4920-4930.
72. Noren Hooten N, Abdelmohsen K, Gorospe M, Ejiogu N, Zonderman AB & Evans MK (2010). microRNA expression patterns reveal differential expression of target genes with age. PLoS One 5, e10724.
73. Nossent AY, Hansen JL, Doggen C, Quax PHA, Sheikh SP & Rosendaal FR (2011). SNPs in microRNA binding sites in 3'-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction. Am J Hypertens 24, 999-1006.
74. Olivieri F, Spazzafumo L, Santini G, Lazzarini R, Albertini MC, Rippo MR, Galeazzi R, Abbatecola AM, Marcheselli F, Monti D, Ostan R, Cevenini E, Antonicelli R, Franceschi C & Procopio AD (2012). Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging. Mech Ageing Dev 133, 675-685.
75. Paneni F, Beckman JA, Creager MA & Cosentino F (2013). Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J 34, 2436-2443.
76. Patrick DM, Montgomery RL, Qi X, Obad S, Kauppinen S, Hill JA, vanRooij E & Olson EN (2010). Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 120, 3912-3916.
77. Paulus WJ & Tschöpe C (2013). A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62, 263-271.
78. Quiat D & Olson EN (2013). MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J Clin Invest 123, 11-18.
79. Quintavalle C, Garofalo M, Croce CM & Condorelli G (2011). 'ApoptomiRs' in vascular cells: their role in physiological and pathological angiogenesis. Vascul Pharmacol 55, 87-91.
80. Rao PK, Toyama Y, Chiang HR, Gupta S, Bauer M, Medvid R, Reinhardt F, Liao R, Krieger M, Jaenisch R, Lodish HF & Blelloch R (2009). Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res 105, 585-594.
81. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR & Ruvkun G (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901-906.
82. Santulli G, Iaccarino G, DeLuca N, Trimarco B & Condorelli G (2014a). Atrial fibrillation and microRNAs. Front Physiol 5, 15.
83. Santulli G, Wronska A, Uryu K, Diacovo TG, Gao M, Marx SO, Kitajewski J, Chilton JM, Akat KM, Tuschl T, Marks AR & Totary-Jain H (2014b). A selective microRNA-based strategy inhibits restenosis while preserving endothelial function. J Clin Invest 124, 4102-4114.
84. Sardu C, Marfella R, Santulli G & Paolisso G (2014). Functional role of miRNA in cardiac resynchronization therapy. Pharmacogenomics 15, 1159-1168.
85. Schober A, Nazari-Jahantigh M & Weber C (2015). MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis. Nat Rev Cardiol 12, 361-374.
86. Schwarz DS, Hutvágner G, Du T, Xu Z, Aronin N & Zamore PD (2003). Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199-208.
87. Seeger T, Haffez F, Fischer A, Koehl U, Leistner DM, Seeger FH, Boon RA, Zeiher AM & Dimmeler S (2013). Immunosenescence-associated microRNAs in age and heart failure. Eur J Heart Fail 15, 385-393.
88. Serna E, Gambini J, Borras C, Abdelaziz KM, Mohammed K, Belenguer A, Sanchis P, Avellana JA, Rodriguez-Mañas L & Viña J (2012). Centenarians, but not octogenarians, up-regulate the expression of microRNAs. Sci Rep 2, 961.
89. Tabuchi T, Satoh M, Itoh T & Nakamura M (2012). MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression. Clin Sci (Lond) 123, 161-171.
90. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G & Hermeking H (2007). Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6, 1586-1593.
91. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J & Engelhardt S (2008). MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984.
92. Tijsen AJ, van der Made I, van den Hoogenhof MM, Wijnen WJ, van Deel ED, de Groot NE, Alekseev S, Fluiter K, Schroen B, Goumans M-J, vander Velden J, Duncker DJ, Pinto YM & Creemers EE (2014). The microRNA-15 family inhibits the TGFβ-pathway in the heart. Cardiovasc Res 104, 61-71.
93. Tritsch E, Mallat Y, Lefebvre F, Diguet N, Escoubet B, Blanc J, DeWindt LJ, Catalucci D, Vandecasteele G, Li Z & Mericskay M (2013). An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart. Cardiovasc Res 98, 372-380.
94. Van Almen GC, Verhesen W, van Leeuwen REW, vande Vrie M, Eurlings C, Schellings MWM, Swinnen M, Cleutjens JPM, van Zandvoort MAMJ, Heymans S & Schroen B (2011). MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell, 769-779.
95. Van Rooij E, Marshall WS & Olson EN (2008a). Toward MicroRNA-based therapeutics for heart disease: the sense in antisense. Circ Res 103, 919-928.
96. Van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J & Olson EN (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575-579.
97. Van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA & Olson EN (2008b). Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105, 13027-13032.
98. Wang J-X, Jiao J-Q, Li Q, Long B, Wang K, Liu J-P, Li Y-R & Li P-F (2011). miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med 17, 71-78.
99. Watson CJ, Gupta SK, O'Connell E, Thum S, Glezeva N, Fendrich J, Gallagher J, Ledwidge M, Grote-Levi L, McDonald K & Thum T (2015). MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure. Eur J Heart Fail 17, 405-415.
100. Wijnen WJ, van der Made I, van den Oever S, Hiller M, de Boer BA, Picavet DI, Chatzispyrou IA, Houtkooper RH, Tijsen AJ, Hagoort J, vanVeen H, Everts V, Ruijter JM, Pinto YM & Creemers EE (2014). Cardiomyocyte-specific miRNA-30c over-expression causes dilated cardiomyopathy. PLoS One 9, e96290.
101. Wronska A, Kurkowska-Jastrzebska I & Santulli G (2015). Application of microRNAs in diagnosis and treatment of cardiovascular disease. Acta Physiol (Oxf) 213, 60-83.
102. Ye Y, Hu Z, Lin Y, Zhang C & Perez-Polo JR (2010). Downregulation of microRNA-29 by antisense inhibitors and a PPAR-γ agonist protects against myocardial ischaemia-reperfusion injury. Cardiovasc Res 87, 535-544.
103. Yuan Q, Chen Z, Santulli G, Gu L, Yang Z-G, Yuan Z-Q, Zhao Y-T, Xin H-B, Deng K-Y, Wang S-Q & Ji G (2014). Functional role of Calstabin2 in age-related cardiac alterations. Sci Rep 4, 7425.
104. Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, Renard J-M, Mayr A, Weger S, Schett G, Shah A, Boulanger CM, Willeit J, Chowienczyk PJ, Kiechl S & Mayr M (2012). Prospective study on circulating microRNAs and risk of myocardial infarction. J Am Coll Cardiol 60, 290-299.
105. Zhang X, Zuo X, Yang B, Li Z, Xue Y, Zhou Y, Huang J, Zhao X, Zhou J, Yan Y, Zhang H, Guo P, Sun H, Guo L, Zhang Y & Fu X-D (2014). MicroRNA directly enhances mitochondrial translation during muscle differentiation. Cell 158, 607-619.
106. Zhuo R, Fu S, Li S, Yao M, Lv D, Xu T & Bei Y (2014). Desregulated microRNAs in aging-related heart failure. Front Genet 5, 186.